Lantheus wins FDA approval for TAUKLARIFY™ F-18 tau PET agent
Lantheus (LNTH) announces FDA approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-labeled tau PET imaging agent for Alzheimer’s disease.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.